Great work from @Xiaowei0402 and team, who I had the privilege of learning from during my rotation in @SynBioGaoLab. A neat approach to engineering functional proteins with defined properties like intracellular stability and low immunogenicity.
We deimmunized a clinical CD19 CAR binder with experimentally detected HLA-I epitope depletion while retaining tumor killing, and rescued a secreted protease to function in the cytosol.
Both done with one unified design framework: ProVADA.
How it works and what we tested ๐งต (1/11)